Physician profile
Todd Giombetti
NPI 1548227119
$368.04
in general payments reported to CMS, 2019-2025
6 companies · $98.93 in 2025
The $98.93 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.75 · 2020: $36.60 · 2021: $32.25 · 2022: $91.90 · 2023: $61.61 · 2025: $98.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $131.63 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $98.33 | 2019-2023 | Rotateq, Vaxelis, Vaqta |
| Glaxosmithkline, LLC. | $47.42 | 2025 | Bexsero, Penmenvy |
| Genentech USA, INC. | $39.15 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $29.86 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $21.65 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Giombetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.